Cargando…
A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago
OBJECTIVES: We tested preliminary efficacy of a peer change agent type I network intervention to increase pre-exposure prophylaxis (PrEP) linkage to care among network members connected to young Black men who have sex with men. DESIGN: Parent study is a pragmatic randomized controlled trial with 110...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722461/ https://www.ncbi.nlm.nih.gov/pubmed/33306562 http://dx.doi.org/10.1097/QAI.0000000000002518 |
_version_ | 1783620158879694848 |
---|---|
author | Schneider, John A. Young, Lindsay Ramachandran, Arthi Michaels, Stuart Cohen, Hildie Robinson, Ishida Alon, Leigh Hill, Brandon Nakasone, Sarah Balenciaga, Mario Motley, Darnell Bouris, Alida Khanna, Aditya Ferreira, Matthew Valente, Thomas Schumm, Phillip |
author_facet | Schneider, John A. Young, Lindsay Ramachandran, Arthi Michaels, Stuart Cohen, Hildie Robinson, Ishida Alon, Leigh Hill, Brandon Nakasone, Sarah Balenciaga, Mario Motley, Darnell Bouris, Alida Khanna, Aditya Ferreira, Matthew Valente, Thomas Schumm, Phillip |
author_sort | Schneider, John A. |
collection | PubMed |
description | OBJECTIVES: We tested preliminary efficacy of a peer change agent type I network intervention to increase pre-exposure prophylaxis (PrEP) linkage to care among network members connected to young Black men who have sex with men. DESIGN: Parent study is a pragmatic randomized controlled trial with 110 weeks of total follow-up. Interim midpoint analyses are performed here using participant data before crossover assignment at 55 weeks. METHODS: We randomly assigned 423 participants in Chicago to receive the network intervention, an opinion leader workshop with telephonic booster sessions, versus a time-matched control from 2016 to 2018. The consolidated surrogate outcome was PrEP referral and linkage to clinical care among network members connected to study participants and was collected from independent administrative data. RESULTS: Each study participant in the trial (n = 423) had on average 1822 network contacts who could be eligible for PrEP referral and linkage. During the 55-week observation period, PrEP referral was most likely to occur within 3 days of an intervention session compared to control [odds ratio (OR) 0.07 (0.02–0.013); P = 0.007] resulting in 1–2 referrals of network members per session. Network members with referral or linkage were more likely to be connected to study participants in the intervention arm than the control condition [aOR 1.50 (1.09–2.06); P = 0.012]. CONCLUSIONS: A peer change agent type I network intervention is preliminarily effective at diffusing PrEP through a network of individuals highly susceptible to HIV over 55 weeks. This low-intensity intervention demonstrated network-level impact among populations that have experienced limited PrEP care engagement in the United States. |
format | Online Article Text |
id | pubmed-7722461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | JAIDS Journal of Acquired Immune Deficiency Syndromes |
record_format | MEDLINE/PubMed |
spelling | pubmed-77224612020-12-31 A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago Schneider, John A. Young, Lindsay Ramachandran, Arthi Michaels, Stuart Cohen, Hildie Robinson, Ishida Alon, Leigh Hill, Brandon Nakasone, Sarah Balenciaga, Mario Motley, Darnell Bouris, Alida Khanna, Aditya Ferreira, Matthew Valente, Thomas Schumm, Phillip J Acquir Immune Defic Syndr Prevention Research OBJECTIVES: We tested preliminary efficacy of a peer change agent type I network intervention to increase pre-exposure prophylaxis (PrEP) linkage to care among network members connected to young Black men who have sex with men. DESIGN: Parent study is a pragmatic randomized controlled trial with 110 weeks of total follow-up. Interim midpoint analyses are performed here using participant data before crossover assignment at 55 weeks. METHODS: We randomly assigned 423 participants in Chicago to receive the network intervention, an opinion leader workshop with telephonic booster sessions, versus a time-matched control from 2016 to 2018. The consolidated surrogate outcome was PrEP referral and linkage to clinical care among network members connected to study participants and was collected from independent administrative data. RESULTS: Each study participant in the trial (n = 423) had on average 1822 network contacts who could be eligible for PrEP referral and linkage. During the 55-week observation period, PrEP referral was most likely to occur within 3 days of an intervention session compared to control [odds ratio (OR) 0.07 (0.02–0.013); P = 0.007] resulting in 1–2 referrals of network members per session. Network members with referral or linkage were more likely to be connected to study participants in the intervention arm than the control condition [aOR 1.50 (1.09–2.06); P = 0.012]. CONCLUSIONS: A peer change agent type I network intervention is preliminarily effective at diffusing PrEP through a network of individuals highly susceptible to HIV over 55 weeks. This low-intensity intervention demonstrated network-level impact among populations that have experienced limited PrEP care engagement in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes 2021-01-01 2021-10-23 /pmc/articles/PMC7722461/ /pubmed/33306562 http://dx.doi.org/10.1097/QAI.0000000000002518 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Prevention Research Schneider, John A. Young, Lindsay Ramachandran, Arthi Michaels, Stuart Cohen, Hildie Robinson, Ishida Alon, Leigh Hill, Brandon Nakasone, Sarah Balenciaga, Mario Motley, Darnell Bouris, Alida Khanna, Aditya Ferreira, Matthew Valente, Thomas Schumm, Phillip A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago |
title | A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago |
title_full | A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago |
title_fullStr | A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago |
title_full_unstemmed | A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago |
title_short | A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago |
title_sort | pragmatic randomized controlled trial to increase prep uptake for hiv prevention: 55-week results from prepchicago |
topic | Prevention Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722461/ https://www.ncbi.nlm.nih.gov/pubmed/33306562 http://dx.doi.org/10.1097/QAI.0000000000002518 |
work_keys_str_mv | AT schneiderjohna apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT younglindsay apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT ramachandranarthi apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT michaelsstuart apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT cohenhildie apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT robinsonishida apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT alonleigh apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT hillbrandon apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT nakasonesarah apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT balenciagamario apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT motleydarnell apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT bourisalida apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT khannaaditya apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT ferreiramatthew apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT valentethomas apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT schummphillip apragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT schneiderjohna pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT younglindsay pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT ramachandranarthi pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT michaelsstuart pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT cohenhildie pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT robinsonishida pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT alonleigh pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT hillbrandon pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT nakasonesarah pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT balenciagamario pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT motleydarnell pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT bourisalida pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT khannaaditya pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT ferreiramatthew pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT valentethomas pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago AT schummphillip pragmaticrandomizedcontrolledtrialtoincreaseprepuptakeforhivprevention55weekresultsfromprepchicago |